Cargando…

Sites of recurrent disease and prognostic factors in SCLC patients treated with radiochemotherapy

OBJECTIVES: Concurrent radiochemotherapy (RCHT) is standard treatment in locally advanced small cell lung cancer (SCLC) patients. Due to conflicting results on elective nodal irradiation (ENI) or selective node irradiation (SNI) there is no clear evidence on optimal target volumes. Therefore, the pu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bütof, Rebecca, Gumina, Calogero, Valentini, Chiara, Sommerer, Antje, Appold, Steffen, Zips, Daniel, Löck, Steffen, Baumann, Michael, Troost, Esther G.C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862679/ https://www.ncbi.nlm.nih.gov/pubmed/29594227 http://dx.doi.org/10.1016/j.ctro.2017.09.010

Ejemplares similares

Impact of Blood Parameters and Normal Tissue Dose on Treatment Outcome in Esophageal Cancer Patients Undergoing Neoadjuvant Radiochemotherapy
por: Bütof, Rebecca, et al.
Publicado: (2022)

PORTAF – postoperative radiotherapy of non-small cell lung cancer: accelerated versus conventional fractionation – study protocol for a randomized controlled trial
por: Bütof, R., et al.
Publicado: (2017)

PRONTOX – proton therapy to reduce acute normal tissue toxicity in locally advanced non-small-cell lung carcinomas (NSCLC): study protocol for a randomised controlled trial
por: Zschaeck, Sebastian, et al.
Publicado: (2016)

Correlation between FMISO-PET based hypoxia in the primary tumour and in lymph node metastases in locally advanced HNSCC patients
por: Bandurska-Luque, Anna, et al.
Publicado: (2019)

Independent validation of tumour volume, cancer stem cell markers and hypoxia-associated gene expressions for HNSCC after primary radiochemotherapy
por: Linge, Annett, et al.
Publicado: (2019)

Impact of waiting time after surgery and overall time of postoperative radiochemotherapy on treatment outcome in glioblastoma multiforme
por: Seidlitz, Annekatrin, et al.
Publicado: (2015)

Retrospective investigation of the prognostic value of the β1 integrin expression in patients with head and neck squamous cell carcinoma receiving primary radio(chemo)therapy
por: Cordes, Nils, et al.
Publicado: (2018)

DNA-Methylome–Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy
por: Tawk, Bouchra, et al.
Publicado: (2023)

Independent validation of the prognostic value of cancer stem cell marker expression and hypoxia-induced gene expression for patients with locally advanced HNSCC after postoperative radiotherapy
por: Linge, Annett, et al.
Publicado: (2016)

Normo- or Hypo-Fractionated Photon or Proton Radiotherapy in the Management of Locally Advanced Unresectable Pancreatic Cancer: A Systematic Review
por: Elkhamisy, Sally A., et al.
Publicado: (2023)

Prognostic biomarkers for the response to the radiosensitizer nimorazole combined with RCTx: a pre-clinical trial in HNSCC xenografts
por: Koi, Lydia, et al.
Publicado: (2023)

The clinical target volume in lung, head-and-neck, and esophageal cancer: Lessons from pathological measurement and recurrence analysis
por: Apolle, Rudi, et al.
Publicado: (2017)

Prognostic value of the micronucleus assay for clinical endpoints in neoadjuvant radiochemotherapy for rectal cancer
por: Dröge, Leif Hendrik, et al.
Publicado: (2021)

Local Control after Locally Ablative, Image-Guided Radiotherapy of Oligometastases Identified by Gallium-68-PSMA-Positron Emission Tomography in Castration-Sensitive Prostate Cancer Patients (OLI-P)
por: Hölscher, Tobias, et al.
Publicado: (2022)

Specific requirements for translation of biological research into clinical radiation oncology
por: Krause, Mechthild, et al.
Publicado: (2020)

Radiochemotherapy
Publicado: (1998)

Development and Validation of a Simplified Prognostic Score in SCLC
por: Negre, Elodie, et al.
Publicado: (2020)

Clinicopathological Difference and Survival Impact of Patients with c-SCLC and SCLC
por: Zhang, Chenyue, et al.
Publicado: (2021)

Impact of robust treatment planning on single- and multi-field optimized plans for proton beam therapy of unilateral head and neck target volumes
por: Cubillos-Mesías, Macarena, et al.
Publicado: (2017)

Dynamics of HMBG1 (High Mobility Group Box 1) during radiochemotherapy correlate with outcome of HNSCC patients
por: Clasen, Kerstin, et al.
Publicado: (2021)

Sonic Hedgehog in SCLC
por: Laukkanen, Mikko O., et al.
Publicado: (2015)

Pathology and Classification of SCLC
por: Raso, Maria Gabriela, et al.
Publicado: (2021)

Resolution of atelectasis during radiochemotherapy of lung cancer with serious implications for further treatment. A case report
por: Braun, Lore Helene, et al.
Publicado: (2017)

Third-Line Nivolumab Monotherapy in Recurrent SCLC: CheckMate 032
por: Ready, Neal, et al.
Publicado: (2018)

Treatment outcome after radiochemotherapy in anal cancer patients staged with (18)F-FDG-PET-CT
por: Braun, L.H., et al.
Publicado: (2020)

Longitudinal and Multimodal Radiomics Models for Head and Neck Cancer Outcome Prediction
por: Starke, Sebastian, et al.
Publicado: (2023)

Plasma sICAM-1 Correlates with Tumor Volume Before Primary Radiochemotherapy of Head and Neck Squamous Cell Carcinoma Patients
por: Clasen, Kerstin, et al.
Publicado: (2022)

Is transformed small cell lung cancer (SCLC) different from de novo SCLC?
por: Park, Cheol-Kyu, et al.
Publicado: (2019)

SDF-1/CXCR4 expression in head and neck cancer and outcome after postoperative radiochemotherapy
por: De-Colle, Chiara, et al.
Publicado: (2017)

ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy
por: Guberina, Maja, et al.
Publicado: (2020)

What Are the Biomarkers for Immunotherapy in SCLC?
por: Longo, Vito, et al.
Publicado: (2021)

Prophylactic cranial irradiation in SCLC
por: Suwinski, Rafal
Publicado: (2021)

MR perfusion measurements on pharyngeal tumors: Comparison of quantification strategies
por: Hietschold, Volker, et al.
Publicado: (2004)

Correction: ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy
por: Guberina, Maja, et al.
Publicado: (2020)

Establishment and Characterisation of Heterotopic Patient-Derived Xenografts for Glioblastoma
por: Meneceur, Sarah, et al.
Publicado: (2020)

Salvage radiotherapy in patients with local recurrent esophageal cancer after radical radiochemotherapy
por: Zhou, Zhi-guo, et al.
Publicado: (2015)

Salvage radiochemotherapy for lymph node recurrence after radical surgery of esophageal cancer
por: Zhou, Yi-Qin, et al.
Publicado: (2018)

Surgery followed by concurrent radiochemotherapy as treatment for patients with locally recurrent cervical cancer
por: Zhang, Xiang, et al.
Publicado: (2021)

Salvage Surgery for Patients With Local Recurrence or Persistent Disease After Treatment With Chemoradiotherapy for SCLC
por: Joosten, Pieter J.M., et al.
Publicado: (2021)

Neoadjuvant Radiochemotherapy Significantly Alters the Phenotype of Plasmacytoid Dendritic Cells and 6-Sulfo LacNAc(+) Monocytes in Rectal Cancer
por: Wagner, Felix, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fuejrs07n42vpatsk1ah8atd4h